Vaxart Inc.

09/10/2025 | Press release | Distributed by Public on 09/10/2025 15:15

Vaxart Reports Additional Phase 1 Data Supporting the Potential Efficacy of its Second-Generation Norovirus Oral Pill Vaccine Candidate

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Vaxart Inc. published this content on September 10, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 10, 2025 at 21:15 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]